DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS). The GBS segment offers a portfolio of analytics services and extensive partner ecosystem that help its customers to gain insights, automate operations, and accelerate their transformation journeys; and software engineering, consulting, and data analytics solutions, which enable businesses to run and manage their mission-critical functions, transform their operations, and develop new ways of doing business. This segment also simplifies, modernize, and accelerate mission-critical applications that support business agility and growth through applications services; provides proprietary modular insurance software and platforms; and operates a wide spectrum of insurance business process services, as well as helps to operate and improve bank cards, payment and lending process and operations, and customer experiences. The GIS segment offers security services, such as IT security, operations and culture for migrating to the cloud, protecting data with a zero-trust strategy, and manage a security operation center; and cloud infrastructure and IT outsourcing services. This segment also delivers a consumer-like experience, centralize IT management, and support services, as well as improves the total cost of ownership; and orchestrates hybrid cloud and multicloud environments. The company markets and sells its products through direct sales force to commercial businesses and public sector enterprises. DXC Technology Company was founded in 1959 and is headquartered in Ashburn, Virginia.

DXC Technology Company

An announcement from Dexus Convenience Retail REIT ( ($AU:DXC) ) is now available. Dexus Convenience Retail REIT’s responsible entity, Dexus Asset ...

Dexus Convenience Retail REIT reshapes board as executive director departs

Dexus Convenience Retail REIT ( ($AU:DXC) ) has shared an update. Dexus Convenience Retail REIT has provided an updated notification to the market ...

Dexus Convenience Retail REIT Reports Daily Progress on On-Market Buy-Back

An announcement from Dexus Convenience Retail REIT ( ($AU:DXC) ) is now available. Dexus Convenience Retail REIT, a specialist owner of convenience...

Dexus Convenience Retail REIT continues on-market security buy-back

An update from Dexus Convenience Retail REIT ( ($AU:DXC) ) is now available. Dexus Convenience Retail REIT has provided an update on its on‑market ...

Dexus Convenience Retail REIT Continues On‑Market Buy‑Back of DXC Securities

Barclays analyst Matt Miksic maintained a Sell rating on Dexcom on May 15 and set a price target of $64.00. The company’s shares closed last Friday...

Barclays Sticks to Its Sell Rating for Dexcom (DXCM)

Traders seeking the hottest stock market stories for Friday will find them in our daily wrap-up.


Morning News Wrap-Up, 5/15/26: Today’s Biggest Stock Market Stories!

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Galectin Therapeutics (GALT) and...

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)

Dexcom ($DXCM) stock jumped about 8% on Friday, at the time of writing, as activist investor Elliott Investment Management took a stake in the make...

Why Is Dexcom Stock (DXCM) Soaring Today?

RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Dexcom today and set a price target of $85.00. According to TipRanks, Singh Chad...

RBC Capital Keeps Their Buy Rating on Dexcom (DXCM)

BTIG analyst Marie Thibault reiterated a Buy rating on Dexcom today and set a price target of $80.00. Thibault covers the Healthcare sector, focusi...

BTIG Keeps Their Buy Rating on Dexcom (DXCM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Bristol-Myers Squibb (BMY) with bu...

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Bristol-Myers Squibb (BMY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biogen (BIIB), RegenXBio (RGNX) and Dexcom (DXCM) wi...

Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), RegenXBio (RGNX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Tonix Pharma (TNXP) with bullish s...

Analysts’ Top Healthcare Picks: Dexcom (DXCM), Tonix Pharma (TNXP)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Information Services Group (III), Fidelity Nationa...

Analysts Conflicted on These Technology Names: Information Services Group (III), Fidelity National Info (FIS) and DXC Technology (DXC)

The latest update is out from Dexus Convenience Retail REIT ( ($AU:DXC) ). Dexus Convenience Retail REIT has issued an updated notification to the ...

Dexus Convenience Retail REIT Updates Details of Ongoing On-Market Buy-Back

Dxc Technology Company (DXC) has disclosed a new risk, in the Technology category. An external analysis indicates that Dxc Technology Company faces...

DXC Technology’s Disaster Readiness Gap: How Systems Failures and Third-Party Dependencies Threaten Operations and Reputation

Dxc Technology Company (($DXC)) has held its Q4 earnings call. Read on for the main highlights of the call. DXC Technology’s latest earnings call p...

DXC Technology Balances AI Progress With Revenue Strain

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on DXC Technology (DXC) and Epam Systems (EPAM). DXC ...

Analysts Offer Insights on Technology Companies: DXC Technology (DXC) and Epam Systems (EPAM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG ...

Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG (CRSP)

An update from Dexus Convenience Retail REIT ( ($AU:DXC) ) is now available. Dexus Convenience Retail REIT, an Australian real estate investment tr...

Dexus Convenience Retail REIT Reports Ongoing On‑Market Buy‑Back Activity

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Dexcom. The company’s shares closed yesterday at $5...

RBC Capital Remains a Buy on Dexcom (DXCM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Dexcom (DXCM) and Merit Medical Syst...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merit Medical Systems (MMSI)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (ILMN), Moderna (MRNA) and Dexcom (DXCM). Illumina (ILMN...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), Moderna (MRNA) and Dexcom (DXCM)

In a report released today, from Jefferies reiterated a Buy rating on Dexcom, with a price target of $112.00. In addition to Jefferies, Dexcom also...

Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)

In a report released yesterday, David Roman from Goldman Sachs maintained a Buy rating on Dexcom, with a price target of $80.00. The company’s shar...

Goldman Sachs Sticks to Their Buy Rating for Dexcom (DXCM)

Stifel Nicolaus analyst reiterated a Buy rating on Dexcom today and set a price target of $85.00. In addition to Stifel Nicolaus, Dexcom also recei...

Dexcom (DXCM) Gets a Buy from Stifel Nicolaus

In a report released today, Brandon Vazquez from William Blair maintained a Buy rating on Dexcom, with a price target of $59.00. According to TipRa...

Dexcom (DXCM) Gets a Buy from William Blair

BTIG analyst Marie Thibault maintained a Buy rating on Dexcom yesterday and set a price target of $80.00. The company’s shares closed yesterday at ...

In a report released today, Matt Miksic from Barclays maintained a Sell rating on Dexcom, with a price target of $67.00. According to TipRanks, Mik...

Barclays Keeps Their Sell Rating on Dexcom (DXCM)

Dexus Convenience Retail REIT ( ($AU:DXC) ) has issued an update. Dexus Convenience Retail REIT has provided an updated daily notification on its o...

Dexus Convenience Retail REIT Updates Buy-Back Totals and Corrects Consideration Figure

An announcement from Dexus Convenience Retail REIT ( ($AU:DXC) ) is now available. Dexus Convenience Retail REIT has cancelled 556,491 fully paid s...

Dexus Convenience Retail REIT Cancels 556,491 Units Under On‑Market Buy‑Back

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Sagimet Biosciences, Inc. Class A ...

Current Quarter	$0.43	Next Quarter	$0.78
Current Year	$2.64	Next Year	$3.24
QoQ Growth	+81.4%	YoY Growth	+22.7%
3Y EPS CAGR	+26.8%	Target Price	$12.13
Consensus	Buy	Upside	+30.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DXC	$9.27	-2.47%	2.31M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DXC	$9.27	-2.5%	2.31M
3
4
5
6

DXC

DXC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get DXC Technology Company Data in Excel

Get DXC Technology Company Data in Excel